$HIPO
Hippo Holdings Inc. Stock $hipo

$hipo Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000162828022006061 Filed on March 14, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$32.10M	$91.20M	$16.40M
YoY Change	95.73%	76.74%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$59.10M	$144.2M	$30.90M
YoY Change	91.26%	35.78%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.300M	$11.00M	$1.900M
YoY Change	73.68%	64.18%
% of Gross Profit
Operating Expenses	$48.70M	$144.2M	$48.50M
YoY Change	0.41%	35.78%
Operating Profit
YoY Change
Interest Expense	-$42.40M	-$198.9M	-$21.80M
YoY Change	94.5%	665.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$59.00M	-$367.2M	-$53.90M
YoY Change	9.46%	156.42%
Income Tax	$300.0K	$700.0K	$100.0K
% Of Pretax Income
Net Earnings	-$60.70M	-$371.4M	-$54.10M
YoY Change	12.2%	162.47%
Net Earnings / Revenue	-189.1%	-407.24%	-329.88%
Basic Earnings Per Share		-$1.36
Diluted Earnings Per Share	-$108.1K	-$1.36	-$96.11K
COMMON SHARES
Basic Shares Outstanding	562.7M shares	272.2M shares
Diluted Shares Outstanding		272.2M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$784.7M		$452.3M
YoY Change	73.49%
Cash & Equivalents	$775.6M	$556.4M	$452.3M
Short-Term Investments	$9.100M		$0.00
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses			$1.075M
Receivables
Other Receivables
Total Short-Term Assets	$41.60M	$41.60M	$1.698M
YoY Change	2350.41%	95.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.100M
YoY Change
Goodwill	$53.50M		$47.80M
YoY Change	11.92%		2415.79%
Intangibles	$32.20M		$33.90M
YoY Change	-5.01%
Long-Term Investments	$64.00M	$64.00M
YoY Change		14.29%
Other Assets	$43.10M	$43.10M
YoY Change		7.48%
Total Long-Term Assets	$1.601B	$1.601B	$977.7M
YoY Change	63.76%	67.11%
TOTAL ASSETS
Total Short-Term Assets	$41.60M	$41.60M	$1.698M
Total Long-Term Assets	$1.601B	$1.601B	$977.7M
Total Assets	$1.643B	$1.643B	$979.4M
YoY Change	67.73%	67.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$41.20M	$41.20M	$139.7K
YoY Change	29395.15%	449.33%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$41.20M	$41.20M	$151.2K
YoY Change	27140.75%	415.0%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$61.70M	$61.70M
YoY Change		-70.84%
Total Long-Term Liabilities	$61.70M	$61.70M
YoY Change		-87.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$41.20M	$41.20M	$151.2K
Total Long-Term Liabilities	$61.70M	$61.70M
Total Liabilities	$781.0M	$783.1M	$834.1M
YoY Change	-6.37%	-6.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$628.0M		-$256.6M
YoY Change	144.74%
Common Stock	$0.00		$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$859.6M	$859.6M	-$199.6M
YoY Change
Total Liabilities & Shareholders Equity	$1.643B	$1.643B	$979.4M
YoY Change	67.73%	67.73%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$60.70M	-$371.4M	-$54.10M
YoY Change	12.2%	162.47%
Depreciation, Depletion And Amortization	$3.300M	$11.00M	$1.900M
YoY Change	73.68%	64.18%
Cash From Operating Activities	$2.600M	-$124.5M	-$29.10M
YoY Change	-108.93%	90.37%
INVESTING ACTIVITIES
Capital Expenditures	-$12.60M	$800.0K	-$2.500M
YoY Change	404.0%	100.0%
Acquisitions		$600.0K
YoY Change		-99.28%
Other Investing Activities	$5.500M	$2.300M	-$24.60M
YoY Change	-122.36%
Cash From Investing Activities	-$7.100M	-$30.00M	-$27.10M
YoY Change	-73.8%	1204.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	400.0K	$480.8M	365.7M
YoY Change	-99.89%	-7.2%
NET CHANGE
Cash From Operating Activities	2.600M	-$124.5M	-29.10M
Cash From Investing Activities	-7.100M	-$30.00M	-27.10M
Cash From Financing Activities	400.0K	$480.8M	365.7M
Net Change In Cash	-4.100M	$326.3M	309.5M
YoY Change	-101.32%	-27.55%
FREE CASH FLOW
Cash From Operating Activities	$2.600M	-$124.5M	-$29.10M
Capital Expenditures	-$12.60M	$800.0K	-$2.500M
Free Cash Flow	$15.20M	-$125.3M	-$26.60M
YoY Change	-157.14%	90.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001828105
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-39711
CY2021	dei	Entity Registrant Name EntityRegistrantName	HIPPO HOLDINGS INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	32-0662604
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	150 Forest Avenue
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Palo Alto
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94301
CY2021	dei	City Area Code CityAreaCode	650
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Local Phone Number LocalPhoneNumber	294-8463
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	228000000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	566266370	shares
CY2021	dei	Auditor Firm AuditorFirmId	42
CY2021	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2021	dei	Auditor Location AuditorLocation	San Francisco, California
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Noncurrent DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent	55600000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Noncurrent DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent	55900000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	54900000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	56000000.0	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	9100000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	64000000.0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	56000000.0	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	775600000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	452300000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	43100000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	40100000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	400000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	500000	USD
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	56500000	USD
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	37100000	USD
CY2021Q4	us-gaap	Reinsurance Recoverables On Paid And Unpaid Losses ReinsuranceRecoverablesOnPaidAndUnpaidLosses	266900000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables On Paid And Unpaid Losses ReinsuranceRecoverablesOnPaidAndUnpaidLosses	134100000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	53500000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	47800000	USD
CY2021Q4	us-gaap	Prepaid Reinsurance Premiums PrepaidReinsurancePremiums	231600000	USD
CY2020Q4	us-gaap	Prepaid Reinsurance Premiums PrepaidReinsurancePremiums	129400000	USD
CY2021Q4	hippo	Ceding Commissions Receivable CedingCommissionsReceivable	41600000	USD
CY2020Q4	hippo	Ceding Commissions Receivable CedingCommissionsReceivable	21300000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	25900000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	14700000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	32200000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	33900000	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	51800000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	12700000	USD
CY2021Q4	us-gaap	Assets Assets	1642700000	USD
CY2020Q4	us-gaap	Assets Assets	979400000	USD
CY2021Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	260800000	USD
CY2020Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	105100000	USD
CY2021Q4	us-gaap	Unearned Premiums UnearnedPremiums	253100000	USD
CY2020Q4	us-gaap	Unearned Premiums UnearnedPremiums	150300000	USD
CY2021Q4	us-gaap	Reinsurance Payable ReinsurancePayable	159400000	USD
CY2020Q4	us-gaap	Reinsurance Payable ReinsurancePayable	86100000	USD
CY2021Q4	hippo	Provision For Commission ProvisionForCommission	12300000	USD
CY2020Q4	hippo	Provision For Commission ProvisionForCommission	28200000	USD
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	0	USD
CY2020Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	273000000.0	USD
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	113300000	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	11600000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	12000000.0	USD
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	22900000	USD
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	83800000	USD
CY2020Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	43200000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	781000000.0	USD
CY2020Q4	us-gaap	Liabilities Liabilities	834100000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	323232460	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	305887443	shares
CY2020Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	305887443	shares
CY2021Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	0	USD
CY2020Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	359400000	USD
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-628000000.0	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	344800000	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	582981484	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	565031129	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	565031129	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	92547013	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	92547013	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1488300000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	56900000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-700000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	100000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-256600000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	859600000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-199600000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	2100000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	100000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	861700000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-199500000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1642700000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	979400000	USD
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	38900000	USD
CY2020	us-gaap	Premiums Earned Net PremiumsEarnedNet	17100000	USD
CY2021	hippo	Insurance Commission Revenue InsuranceCommissionRevenue	37500000	USD
CY2020	hippo	Insurance Commission Revenue InsuranceCommissionRevenue	27100000	USD
CY2021	hippo	Service And Fee Income ServiceAndFeeIncome	14500000	USD
CY2020	hippo	Service And Fee Income ServiceAndFeeIncome	6300000	USD
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	300000	USD
CY2020	hippo	Technology And Development Expense TechnologyAndDevelopmentExpense	18000000.0	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	95000000.0	USD
CY2020	us-gaap	Net Investment Income NetInvestmentIncome	1100000	USD
CY2021	us-gaap	Revenues Revenues	91200000	USD
CY2020	us-gaap	Revenues Revenues	51600000	USD
CY2021	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	84400000	USD
CY2020	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	25300000	USD
CY2021	us-gaap	Liability For Future Policy Benefits Period Expense LiabilityForFuturePolicyBenefitsPeriodExpense	41700000	USD
CY2020	us-gaap	Liability For Future Policy Benefits Period Expense LiabilityForFuturePolicyBenefitsPeriodExpense	19300000	USD
CY2021	hippo	Technology And Development Expense TechnologyAndDevelopmentExpense	36200000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	69400000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	49200000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36800000	USD
CY2021	hippo	Interest And Other Expense Income Net InterestAndOtherExpenseIncomeNet	198900000	USD
CY2020	hippo	Interest And Other Expense Income Net InterestAndOtherExpenseIncomeNet	26000000.0	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	47000000.0	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	458400000	USD
CY2020	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	194800000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-367200000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-143200000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	700000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1800000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-367900000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-141400000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3500000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	100000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-371400000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-141500000	USD
CY2021	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-800000	USD
CY2020	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-372200000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-141500000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-371400000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-371400000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-141500000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-141500000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	272168933	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	272168933	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86897893	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86897893	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.36
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.36
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.63
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.63
CY2019Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	250604066	shares
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	190300000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-78300000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-141400000	USD
CY2021	hippo	Temporary Equity Amount Conversion Of Convertible Securities TemporaryEquityAmountConversionOfConvertibleSecurities	518200000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	518200000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2500000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17700000	USD
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	305887443	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	344800000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-199500000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-367900000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-800000	USD
CY2021	hippo	Temporary Equity Shares Exercise Of Preferred Stock Warrants TemporaryEquitySharesExerciseOfPreferredStockWarrants	17344906	shares
CY2021	hippo	Temporary Equity Amount Exercise Of Preferred Stock Warrants TemporaryEquityAmountExerciseOfPreferredStockWarrants	173400000	USD
CY2021	hippo	Temporary Equity Shares Conversion Of Convertible Securities TemporaryEquitySharesConversionOfConvertibleSecurities	323232349	shares
CY2021	hippo	Stock Issued During Period Value Conversion Of Convertible Debt StockIssuedDuringPeriodValueConversionOfConvertibleDebt	434500000	USD
CY2021	hippo	Stock Issued During Period Value Business Combination StockIssuedDuringPeriodValueBusinessCombination	453900000	USD
CY2021	hippo	Adjustments To Additional Paid In Capital Warrants Acquired AdjustmentsToAdditionalPaidInCapitalWarrantsAcquired	14600000	USD
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	6200000	USD
CY2021	hippo	Stock Issued During Period Value Stock Options Exercised And Vesting Of Restricted Stock Unit StockIssuedDuringPeriodValueStockOptionsExercisedAndVestingOfRestrictedStockUnit	5200000	USD
CY2021	hippo	Stock Issued During Period Value Share Based Compensation Early Exercised Options Vested StockIssuedDuringPeriodValueShareBasedCompensationEarlyExercisedOptionsVested	800000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	27200000	USD
CY2021	us-gaap	Stockholders Equity Other StockholdersEquityOther	1500000	USD
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	861700000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-367900000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-141400000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11000000.0	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6700000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	24300000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	17200000	USD
CY2021	hippo	Fair Value Adjustment Of Preferred Stock Warrants FairValueAdjustmentOfPreferredStockWarrants	121600000	USD
CY2020	hippo	Fair Value Adjustment Of Preferred Stock Warrants FairValueAdjustmentOfPreferredStockWarrants	16200000	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-10300000	USD
CY2020	hippo	Noncash Service Expense NoncashServiceExpense	0	USD
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3500000	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3400000	USD
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-61400000	USD
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-6200000	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	20400000	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	47000000.0	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Paid In Kind Interest PaidInKindInterest	5700000	USD
CY2020	us-gaap	Paid In Kind Interest PaidInKindInterest	0	USD
CY2021	hippo	Noncash Service Expense NoncashServiceExpense	7000000.0	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2100000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1300000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19500000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	14700000	USD
CY2021	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	132800000	USD
CY2020	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	17700000	USD
CY2021	hippo	Increase Decrease In Ceding Commissions Receivable IncreaseDecreaseInCedingCommissionsReceivable	20300000	USD
CY2020	hippo	Increase Decrease In Ceding Commissions Receivable IncreaseDecreaseInCedingCommissionsReceivable	3400000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Reinsurance Premiums IncreaseDecreaseInPrepaidReinsurancePremiums	102200000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Reinsurance Premiums IncreaseDecreaseInPrepaidReinsurancePremiums	-2500000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	32800000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	7800000	USD
CY2021	hippo	Increase Decrease In Provision For Commission IncreaseDecreaseInProvisionForCommission	-15900000	USD
CY2020	hippo	Increase Decrease In Provision For Commission IncreaseDecreaseInProvisionForCommission	15300000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	35400000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	10900000	USD
CY2021	us-gaap	Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve	155700000	USD
CY2020	us-gaap	Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve	11800000	USD
CY2021	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	102800000	USD
CY2020	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	18100000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	600000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	83700000	USD
CY2021	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	73300000	USD
CY2020	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	10000000.0	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-124500000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-65400000	USD
CY2021	us-gaap	Payments For Software PaymentsForSoftware	13300000	USD
CY2020	us-gaap	Payments For Software PaymentsForSoftware	9000000.0	USD
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3300000	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	800000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	400000	USD
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	26200000	USD
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	16700000	USD
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	5800000	USD
CY2020	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	76800000	USD
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	10700000	USD
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	30700000	USD
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	2300000	USD
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-30000000.0	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2300000	USD
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	29000000.0	USD
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2021	hippo	Proceeds From Reverse Recapitalization Net Of Redemptions Secondaries And Costs ProceedsFromReverseRecapitalizationNetOfRedemptionsSecondariesAndCosts	450300000	USD
CY2020	hippo	Proceeds From Reverse Recapitalization Net Of Redemptions Secondaries And Costs ProceedsFromReverseRecapitalizationNetOfRedemptionsSecondariesAndCosts	0	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5500000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2400000	USD
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	2400000	USD
CY2020	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	3900000	USD
CY2021	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	0	USD
CY2020	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	365000000.0	USD
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1600000	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	480800000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	518100000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	326300000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	450400000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	492400000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	42000000.0	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	818700000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	492400000	USD
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	518200000	USD
CY2020	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	434500000	USD
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2021	hippo	Acquisition Of Public And Private Warrants AcquisitionOfPublicAndPrivateWarrants	14600000	USD
CY2020	hippo	Acquisition Of Public And Private Warrants AcquisitionOfPublicAndPrivateWarrants	0	USD
CY2021	us-gaap	Notes Issued1 NotesIssued1	7000000.0	USD
CY2020	us-gaap	Notes Issued1 NotesIssued1	12500000	USD
CY2021	us-gaap	Stock Issued1 StockIssued1	6200000	USD
CY2020	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2021Q4	hippo	Number Of States Licensed As Insurance Agency NumberOfStatesLicensedAsInsuranceAgency	50	state
CY2021Q4	hippo	Number Of States Acting As Managing General Agent With Underwriting And Distributing Of Policies NumberOfStatesActingAsManagingGeneralAgentWithUnderwritingAndDistributingOfPolicies	37	state
CY2021	us-gaap	Reinsurance Retention Policy Reinsured Risk Percentage ReinsuranceRetentionPolicyReinsuredRiskPercentage	0.12
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Significant items subject to such estimates and assumptions include, but are not limited to, loss and loss adjustment expense (“LAE”) reserves, provision for commission slide and cancellations, reinsurance recoverable on paid and unpaid losses and LAE, the fair values of investments,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common stock, stock-based awards, warrant liabilities, contingent consideration liabilities, embedded derivative liabilities, acquired intangible assets and goodwill, deferred tax assets and uncertain tax positions, and revenue recognition. The Company evaluates these estimates on an ongoing basis. These estimates are informed by experience and other assumptions that the Company believes are reasonable under the circumstances. Actual results may differ significantly from these estimates.</span>
CY2020	us-gaap	Depreciation Depreciation	400000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk are primarily comprised of cash and cash equivalents, short-term investments, fixed maturities available-for-sale, and reinsurance recoverables. Cash deposits may, at times, exceed amounts insured by the Federal Deposit Insurance Corporation and the Securities Investor Protection Corporation. However, its exposure to credit risk in the event of default by the financial institutions is limited to the extent of amounts recorded on the balance sheet. The Company performs evaluations of the relative credit standing of these financial institutions to limit the amount of credit exposure. The Company has not experienced any losses on its deposits of cash and cash equivalents to date. The Company limits its exposure to credit losses by investing in money market funds, U.S. government securities, or securities with average credit quality of AA- or better. Premium receivables are a mix of receivables due from policyholders, agents, and program administrators. The Company has no significant off-balance-sheet concentration of credit risks such as foreign exchange contracts, option contracts, or other foreign hedging arrangements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into quota share and excess of loss contracts which may be susceptible to catastrophe exposure. The ceding of insurance does not legally discharge the Company from its primary liability for the full amount of the policy coverage, and therefore the Company will be required to pay the loss and bear collection risk if the reinsurer fails to meet its obligations under the reinsurance agreement. To minimize exposure to significant losses from reinsurance insolvencies, the Company evaluates the financial condition of its reinsurers, monitors concentrations of credit risk and, in certain circumstances, holds substantial collateral (in the form of funds withheld and letters of credit) as security under the reinsurance agreements.</span></div>
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	400000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	500000	USD
CY2021	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	13900000	USD
CY2020	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	3700000	USD
CY2021	us-gaap	Premium Deficiency Testing Expense Long Duration Contract Amount PremiumDeficiencyTestingExpenseLongDurationContractAmount	300000	USD
CY2020	hippo	Policy Fees Revenue PolicyFeesRevenue	2600000	USD
CY2021	hippo	Insurance Commission Revenue Managing General Agent InsuranceCommissionRevenueManagingGeneralAgent	2600000	USD
CY2020	us-gaap	Premium Deficiency Testing Expense Long Duration Contract Amount PremiumDeficiencyTestingExpenseLongDurationContractAmount	0	USD
CY2021	us-gaap	Depreciation Depreciation	400000	USD
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	38900000	USD
CY2020	us-gaap	Premiums Earned Net PremiumsEarnedNet	17100000	USD
CY2021	hippo	Ceding Commissions CedingCommissions	21300000	USD
CY2020	hippo	Ceding Commissions CedingCommissions	1200000	USD
CY2021	hippo	Insurance Commission Revenue Agency InsuranceCommissionRevenueAgency	12300000	USD
CY2020	hippo	Insurance Commission Revenue Agency InsuranceCommissionRevenueAgency	8400000	USD
CY2021	hippo	Policy Fees Revenue PolicyFeesRevenue	10900000	USD
CY2020	hippo	Insurance Commission Revenue Managing General Agent InsuranceCommissionRevenueManagingGeneralAgent	12800000	USD
CY2021	hippo	Claims Processing Fees Revenue ClaimsProcessingFeesRevenue	1300000	USD
CY2020	hippo	Claims Processing Fees Revenue ClaimsProcessingFeesRevenue	4600000	USD
CY2021	us-gaap	Other Income OtherIncome	3600000	USD
CY2020	us-gaap	Other Income OtherIncome	3800000	USD
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	300000	USD
CY2020	us-gaap	Net Investment Income NetInvestmentIncome	1100000	USD
CY2021	us-gaap	Revenues Revenues	91200000	USD
CY2020	us-gaap	Revenues Revenues	51600000	USD
CY2021	us-gaap	Advertising Expense AdvertisingExpense	28900000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	12200000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	47000000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	55000000	shares
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	550000000	USD
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	559731226	shares
CY2021Q3	hippo	Proceeds From Reverse Capitalization Gross ProceedsFromReverseCapitalizationGross	587700000	USD
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	550000000	USD
CY2021Q3	hippo	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	37700000	USD
CY2021Q3	hippo	Reverse Recapitalization Cash Paid To Repurchase Shares ReverseRecapitalizationCashPaidToRepurchaseShares	95000000	USD
CY2021Q3	hippo	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	42400000	USD
CY2021Q3	hippo	Stock Converted Reverse Recapitalization StockConvertedReverseRecapitalization	495242606	shares
CY2021	hippo	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	37700000	USD
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	550000000.0	USD
CY2021	hippo	Reverse Recapitalization Cash Paid To Repurchase Shares ReverseRecapitalizationCashPaidToRepurchaseShares	95000000.0	USD
CY2021	hippo	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	42400000	USD
CY2021	hippo	Reverse Recapitalization Net ReverseRecapitalizationNet	450300000	USD
CY2021	hippo	Reverse Recapitalization Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net ReverseRecapitalizationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	3600000	USD
CY2021	hippo	Reverse Recapitalization Net Including Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net ReverseRecapitalizationNetIncludingRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	453900000	USD
CY2021Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	55000000	shares
CY2021Q3	hippo	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	64488620	shares
CY2021Q3	hippo	Stock Converted Reverse Recapitalization StockConvertedReverseRecapitalization	495242606	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	559731226	shares
CY2021Q3	hippo	Instrument Converted Recapitalization Exchange Ratio InstrumentConvertedRecapitalizationExchangeRatio	6.95433
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Noncurrent DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent	55600000	USD
CY2021Q4	hippo	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Before Tax Noncurrent DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent	0	USD
CY2021Q4	hippo	Debt Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax Noncurrent DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent	700000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	54900000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	64700000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	700000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	64000000.0	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Noncurrent DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent	55900000	USD
CY2020Q4	hippo	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Before Tax Noncurrent DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent	100000	USD
CY2020Q4	hippo	Debt Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax Noncurrent DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	56000000.0	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	0	security
CY2020	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	10500000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	10500000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	18300000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	18100000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	4500000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	4400000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Noncurrent DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent	55600000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	54900000	USD
CY2021	hippo	Investment Income Debt Securities Available For Sale InvestmentIncomeDebtSecuritiesAvailableForSale	400000	USD
CY2020	hippo	Investment Income Debt Securities Available For Sale InvestmentIncomeDebtSecuritiesAvailableForSale	1100000	USD
CY2021	hippo	Investment Income Short Term InvestmentIncomeShortTerm	0	USD
CY2020	hippo	Investment Income Short Term InvestmentIncomeShortTerm	0	USD
CY2021	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	400000	USD
CY2020	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	1100000	USD
CY2021	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	100000	USD
CY2020	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	0	USD
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	300000	USD
CY2020	us-gaap	Net Investment Income NetInvestmentIncome	1100000	USD
CY2021Q4	hippo	Debt Securities Available For Sale Special Deposits Amortized Cost DebtSecuritiesAvailableForSaleSpecialDepositsAmortizedCost	8400000	USD
CY2021Q4	hippo	Debt Securities Available For Sale Special Deposits DebtSecuritiesAvailableForSaleSpecialDeposits	8600000	USD
CY2020Q4	hippo	Debt Securities Available For Sale Special Deposits Amortized Cost DebtSecuritiesAvailableForSaleSpecialDepositsAmortizedCost	8400000	USD
CY2020Q4	hippo	Debt Securities Available For Sale Special Deposits DebtSecuritiesAvailableForSaleSpecialDeposits	8400000	USD
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	620400000	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	11600000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	775600000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	452300000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	43100000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	40100000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	818700000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	492400000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	556400000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	54900000	USD
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	15900000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	395600000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	56000000.0	USD
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	451600000	USD
CY2020Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	113300000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	12000000.0	USD
CY2020Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	148200000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	1900000	USD
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	45900000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	47800000	USD
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	5200000	USD
CY2021	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	500000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	53500000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	33900000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5700000	USD
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	43400000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11200000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3700000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	32200000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	39400000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5500000	USD
CY2020	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	0	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5200000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4200000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4000000.0	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2400000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1700000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	4200000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	21700000	USD
CY2021Q4	hippo	Premium Refund Liability PremiumRefundLiability	4800000	USD
CY2020Q4	hippo	Warrant Liability WarrantLiability	0	USD
CY2021Q4	hippo	Fiduciary Liability FiduciaryLiability	3700000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	34500000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	18400000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	8600000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	3700000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	25900000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	14700000	USD
CY2021	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	4900000	USD
CY2020	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	2600000	USD
CY2020Q4	hippo	Premium Refund Liability PremiumRefundLiability	2600000	USD
CY2021Q4	hippo	Warrant Liability WarrantLiability	4300000	USD
CY2020Q4	hippo	Fiduciary Liability FiduciaryLiability	5000000.0	USD
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	13600000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	12100000	USD
CY2021Q4	hippo	Claim Payments Outstanding ClaimPaymentsOutstanding	23200000	USD
CY2020Q4	hippo	Claim Payments Outstanding ClaimPaymentsOutstanding	9900000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	11200000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1700000	USD
CY2021Q4	hippo	Advances From Customers AdvancesFromCustomers	8700000	USD
CY2020Q4	hippo	Advances From Customers AdvancesFromCustomers	4400000	USD
CY2021Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	8500000	USD
CY2020Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	5000000.0	USD
CY2021Q4	hippo	Accrued Licenses And Taxes AccruedLicensesAndTaxes	5800000	USD
CY2020Q4	hippo	Accrued Licenses And Taxes AccruedLicensesAndTaxes	2500000	USD
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	83800000	USD
CY2020Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	43200000	USD
CY2021	us-gaap	Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense	<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the beginning and ending reserve balances for losses and loss adjustment expenses, net of reinsurance is summarized as follows for the year ended December 31, (in millions): </span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.833%"><tr><td style="width:1.0%"/><td style="width:71.809%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reserve for losses and LAE gross of reinsurance recoverables on unpaid losses and LAE as of beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reinsurance recoverables on unpaid losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(92.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reserve for losses and LAE, net of reinsurance recoverables as of beginning of the period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Add: Incurred losses and LAE, net of reinsurance, related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deduct: Loss and LAE payments, net of reinsurance, related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prior year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reserve for losses and LAE, net of reinsurance recoverables acquired from Spinnaker</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reserve for losses and LAE, net of reinsurance recoverables at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables on unpaid losses and LAE at end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">216.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">92.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reserve for losses and LAE gross of reinsurance recoverables on unpaid losses and LAE as of end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">260.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>
CY2020Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	105100000	USD
CY2019Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	0	USD
CY2020Q4	us-gaap	Reinsurance Recoverable For Unpaid Claims And Claims Adjustments ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments	92100000	USD
CY2019Q4	us-gaap	Reinsurance Recoverable For Unpaid Claims And Claims Adjustments ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments	0	USD
CY2020Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Net LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet	13000000.0	USD
CY2019Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Net LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet	0	USD
CY2021	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	85000000.0	USD
CY2020	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	25300000	USD
CY2021	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-600000	USD
CY2020	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	0	USD
CY2021	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	84400000	USD
CY2020	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	25300000	USD
CY2021	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	43600000	USD
CY2020	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	17000000.0	USD
CY2021	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	9800000	USD
CY2020	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	300000	USD
CY2021	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	53400000	USD
CY2020	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	17300000	USD
CY2021Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Net LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet	44000000.0	USD
CY2020Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Net LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet	13000000.0	USD
CY2021Q4	us-gaap	Reinsurance Recoverable For Unpaid Claims And Claims Adjustments ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments	216800000	USD
CY2020Q4	us-gaap	Reinsurance Recoverable For Unpaid Claims And Claims Adjustments ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments	92100000	USD
CY2021Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	260800000	USD
CY2020Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	105100000	USD
CY2021	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-600000	USD
CY2021	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-600000	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021Q4	us-gaap	Shortduration Insurance Contracts Incurred Claims And Allocated Claim Adjustment Expense Net ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet	122100000	USD
CY2021Q4	us-gaap	Shortduration Insurance Contracts Incurred But Not Reported Ibnr Claims Liability Net ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet	34100000	USD
CY2021Q4	us-gaap	Shortduration Insurance Contracts Number Of Reported Claims ShortdurationInsuranceContractsNumberOfReportedClaims	91835	claim
CY2021Q4	us-gaap	Shortduration Insurance Contracts Cumulative Paid Claims And Allocated Claim Adjustment Expense Net ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet	78100000	USD
CY2021Q4	us-gaap	Shortduration Insurance Contracts Liability For Unpaid Claims And Allocated Claim Adjustment Expense Net ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet	44000000.0	USD
CY2021Q4	us-gaap	Reinsurance Recoverable For Unpaid Claims And Claims Adjustments ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments	216800000	USD
CY2021Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	260800000	USD
CY2021	hippo	Current Year Claims And Development Table Adjustment Claims Adjustment Expense CurrentYearClaimsAndDevelopmentTableAdjustmentClaimsAdjustmentExpense	76700000	USD
CY2021	hippo	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Development Table Current Year LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidDevelopmentTableCurrentYear	35200000	USD
CY2021	hippo	Current Year Claims And Unallocated Loss Claims Adjustment Expense CurrentYearClaimsAndUnallocatedLossClaimsAdjustmentExpense	8300000	USD
CY2021	hippo	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Unallocated Loss Current Year LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidUnallocatedLossCurrentYear	8300000	USD
CY2021	hippo	Current Year Claims And Other Claims Adjustment Expense CurrentYearClaimsAndOtherClaimsAdjustmentExpense	0	USD
CY2021	hippo	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Other Current Year LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidOtherCurrentYear	100000	USD
CY2021	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	85000000.0	USD
CY2021	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	43600000	USD
CY2020	hippo	Current Year Claims And Development Table Adjustment Claims Adjustment Expense CurrentYearClaimsAndDevelopmentTableAdjustmentClaimsAdjustmentExpense	28100000	USD
CY2020	hippo	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Development Table Current Year LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidDevelopmentTableCurrentYear	17100000	USD
CY2020	hippo	Current Year Claims And Unallocated Loss Claims Adjustment Expense CurrentYearClaimsAndUnallocatedLossClaimsAdjustmentExpense	2200000	USD
CY2020	hippo	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Unallocated Loss Current Year LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidUnallocatedLossCurrentYear	-2100000	USD
CY2020	hippo	Current Year Claims And Liability For Claims And Claims Adjustment Expense Before Acquisition CurrentYearClaimsAndLiabilityForClaimsAndClaimsAdjustmentExpenseBeforeAcquisition	-5000000.0	USD
CY2021	us-gaap	Reinsurance Retention Policy Reinsured Risk Percentage ReinsuranceRetentionPolicyReinsuredRiskPercentage	0.12
CY2020	hippo	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Liability For Claims And Claims Adjustment Expense Before Acquisition Current Year LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidLiabilityForClaimsAndClaimsAdjustmentExpenseBeforeAcquisitionCurrentYear	2000000.0	USD
CY2020	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	25300000	USD
CY2020	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	17000000.0	USD
CY2021Q4	hippo	Reinsurance Number Of Third Party Reinsures ReinsuranceNumberOfThirdPartyReinsures	9	reinsurer
CY2021	us-gaap	Reinsurance Loss On Uncollectible Accounts In Period Amount ReinsuranceLossOnUncollectibleAccountsInPeriodAmount	0	USD
CY2020	us-gaap	Reinsurance Loss On Uncollectible Accounts In Period Amount ReinsuranceLossOnUncollectibleAccountsInPeriodAmount	0	USD
CY2021	hippo	Liability For Claims And Claims Adjustment Expense Reserve Direct LiabilityForClaimsAndClaimsAdjustmentExpenseReserveDirect	253400000	USD
CY2021	hippo	Direct Unearned Premiums DirectUnearnedPremiums	246600000	USD
CY2020	hippo	Liability For Claims And Claims Adjustment Expense Reserve Direct LiabilityForClaimsAndClaimsAdjustmentExpenseReserveDirect	102700000	USD
CY2020	hippo	Direct Unearned Premiums DirectUnearnedPremiums	143700000	USD
CY2021	hippo	Liability For Claims And Claims Adjustment Expense Reserve Assumed LiabilityForClaimsAndClaimsAdjustmentExpenseReserveAssumed	7400000	USD
CY2021	hippo	Assumed Unearned Premiums AssumedUnearnedPremiums	6500000	USD
CY2020	hippo	Liability For Claims And Claims Adjustment Expense Reserve Assumed LiabilityForClaimsAndClaimsAdjustmentExpenseReserveAssumed	2400000	USD
CY2020	hippo	Assumed Unearned Premiums AssumedUnearnedPremiums	6600000	USD
CY2021	hippo	Liability For Claims And Claims Adjustment Expense Reserve Gross LiabilityForClaimsAndClaimsAdjustmentExpenseReserveGross	260800000	USD
CY2021	hippo	Unearned Premiums Gross UnearnedPremiumsGross	253100000	USD
CY2020	hippo	Liability For Claims And Claims Adjustment Expense Reserve Gross LiabilityForClaimsAndClaimsAdjustmentExpenseReserveGross	105100000	USD
CY2020	hippo	Unearned Premiums Gross UnearnedPremiumsGross	150300000	USD
CY2021	hippo	Liability For Claims And Claims Adjustment Expense Reserve Ceded LiabilityForClaimsAndClaimsAdjustmentExpenseReserveCeded	216800000	USD
CY2021	hippo	Ceded Unearned Premiums CededUnearnedPremiums	231600000	USD
CY2020	hippo	Liability For Claims And Claims Adjustment Expense Reserve Ceded LiabilityForClaimsAndClaimsAdjustmentExpenseReserveCeded	92100000	USD
CY2020	hippo	Ceded Unearned Premiums CededUnearnedPremiums	129400000	USD
CY2021	hippo	Liability For Claims And Claims Adjustment Expense Reserve Net LiabilityForClaimsAndClaimsAdjustmentExpenseReserveNet	44000000.0	USD
CY2021	hippo	Unearned Premiums Net UnearnedPremiumsNet	21500000	USD
CY2020	hippo	Liability For Claims And Claims Adjustment Expense Reserve Net LiabilityForClaimsAndClaimsAdjustmentExpenseReserveNet	13000000.0	USD
CY2020	hippo	Unearned Premiums Net UnearnedPremiumsNet	20900000	USD
CY2021	us-gaap	Direct Premiums Written DirectPremiumsWritten	474000000.0	USD
CY2021	us-gaap	Direct Premiums Earned DirectPremiumsEarned	364700000	USD
CY2021	hippo	Liability For Claims And Claims Adjustment Expense Incurred Direct LiabilityForClaimsAndClaimsAdjustmentExpenseIncurredDirect	498500000	USD
CY2020	us-gaap	Direct Premiums Written DirectPremiumsWritten	90000000.0	USD
CY2020	us-gaap	Direct Premiums Earned DirectPremiumsEarned	88700000	USD
CY2020	hippo	Liability For Claims And Claims Adjustment Expense Incurred Direct LiabilityForClaimsAndClaimsAdjustmentExpenseIncurredDirect	93600000	USD
CY2021	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	3300000	USD
CY2021	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	9800000	USD
CY2021	hippo	Liability For Claims And Claims Adjustment Expense Incurred Assumed LiabilityForClaimsAndClaimsAdjustmentExpenseIncurredAssumed	16900000	USD
CY2020	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	26100000	USD
CY2020	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	9300000	USD
CY2020	hippo	Liability For Claims And Claims Adjustment Expense Incurred Assumed LiabilityForClaimsAndClaimsAdjustmentExpenseIncurredAssumed	13300000	USD
CY2021	us-gaap	Premiums Written Gross PremiumsWrittenGross	477300000	USD
CY2021	hippo	Premiums Earned Gross PremiumsEarnedGross	374500000	USD
CY2021	hippo	Liability For Claims And Claims Adjustment Expense Incurred Gross LiabilityForClaimsAndClaimsAdjustmentExpenseIncurredGross	515400000	USD
CY2020	us-gaap	Premiums Written Gross PremiumsWrittenGross	116100000	USD
CY2020	hippo	Premiums Earned Gross PremiumsEarnedGross	98000000.0	USD
CY2020	hippo	Liability For Claims And Claims Adjustment Expense Incurred Gross LiabilityForClaimsAndClaimsAdjustmentExpenseIncurredGross	106900000	USD
CY2021	us-gaap	Ceded Premiums Written CededPremiumsWritten	434800000	USD
CY2021	us-gaap	Ceded Premiums Earned CededPremiumsEarned	335600000	USD
CY2021	hippo	Liability For Claims And Claims Adjustment Expense Incurred Ceded LiabilityForClaimsAndClaimsAdjustmentExpenseIncurredCeded	431000000.0	USD
CY2020	us-gaap	Ceded Premiums Written CededPremiumsWritten	78400000	USD
CY2020	us-gaap	Ceded Premiums Earned CededPremiumsEarned	80900000	USD
CY2020	hippo	Liability For Claims And Claims Adjustment Expense Incurred Ceded LiabilityForClaimsAndClaimsAdjustmentExpenseIncurredCeded	81600000	USD
CY2021	us-gaap	Premiums Written Net PremiumsWrittenNet	42500000	USD
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	38900000	USD
CY2021	hippo	Liability For Claims And Claims Adjustment Expense Incurred Net LiabilityForClaimsAndClaimsAdjustmentExpenseIncurredNet	84400000	USD
CY2020	us-gaap	Premiums Written Net PremiumsWrittenNet	37700000	USD
CY2020	us-gaap	Premiums Earned Net PremiumsEarnedNet	17100000	USD
CY2020	hippo	Liability For Claims And Claims Adjustment Expense Incurred Net LiabilityForClaimsAndClaimsAdjustmentExpenseIncurredNet	25300000	USD
CY2021Q4	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	50100000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	42000000.0	USD
CY2021Q4	us-gaap	Reinsurance Recoverable For Unpaid Claims And Claims Adjustments ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments	216800000	USD
CY2020Q4	us-gaap	Reinsurance Recoverable For Unpaid Claims And Claims Adjustments ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments	92100000	USD
CY2021Q4	us-gaap	Reinsurance Recoverables On Paid And Unpaid Losses ReinsuranceRecoverablesOnPaidAndUnpaidLosses	266900000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables On Paid And Unpaid Losses ReinsuranceRecoverablesOnPaidAndUnpaidLosses	134100000	USD
CY2021Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	321100000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	162500000	USD
CY2021	us-gaap	Premiums Written Gross PremiumsWrittenGross	477300000	USD
CY2020	us-gaap	Premiums Written Gross PremiumsWrittenGross	116100000	USD
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	3100000	USD
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2800000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	4100000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	5100000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	5200000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	5200000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	4200000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	5200000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	29000000.0	USD
CY2021	hippo	Purchase Obligation Term PurchaseObligationTerm	P3Y
CY2021Q4	us-gaap	Purchase Obligation PurchaseObligation	34600000	USD
CY2020Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	323232460	shares
CY2020Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	305887443	shares
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	305887443	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	344800000	USD
CY2020Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	359400000	USD
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	hippo	Instrument Converted Recapitalization Outstanding InstrumentConvertedRecapitalizationOutstanding	504742606	shares
CY2021Q3	hippo	Stock Converted Reverse Recapitalization StockConvertedReverseRecapitalization	495242606	shares
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	55000000	shares
CY2021Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	550000000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	72205242	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.70
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y10M24D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.16
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.70
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	108900000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	9686589	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.81
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	22801742	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.33
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	11551163	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.05
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	47538926	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.39
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y3M18D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	84800000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	15919802	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.81
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y10M17D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	32900000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	41600000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	15400000	USD
CY2021Q3	hippo	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Forgiveness ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodForgiveness	9400000	shares
CY2021Q3	hippo	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Forgiveness Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodForgivenessIntrinsicValue	94000000	USD
CY2021Q4	hippo	Share Based Payment Arrangement Plan Modification Incremental Cost Number Of Shares Subject To Repurchase ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfSharesSubjectToRepurchase	2948602	shares
CY2021Q4	hippo	Share Based Compensation Arrangement By Share Based Payment Award Early Exercise Of Stock Options Liability For Unvested Awards ShareBasedCompensationArrangementByShareBasedPaymentAwardEarlyExerciseOfStockOptionsLiabilityForUnvestedAwards	2200000	USD
CY2020Q4	hippo	Share Based Compensation Arrangement By Share Based Payment Award Early Exercise Of Stock Options Liability For Unvested Awards ShareBasedCompensationArrangementByShareBasedPaymentAwardEarlyExerciseOfStockOptionsLiabilityForUnvestedAwards	2500000	USD
CY2021Q4	hippo	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Subject To Repurchase Related To Early Exercise Of Stock Option ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesSubjectToRepurchaseRelatedToEarlyExerciseOfStockOption	2060221	shares
CY2020Q4	hippo	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Subject To Repurchase Related To Early Exercise Of Stock Option ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesSubjectToRepurchaseRelatedToEarlyExerciseOfStockOption	2399245	shares
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24300000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17200000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-371300000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-143200000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	600000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	USD
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-370700000	USD
CY2020	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-143200000	USD
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-370700000	USD
CY2020	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-143200000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-77900000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-30100000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	100000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	100000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	27800000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	8100000	USD
CY2021	hippo	Effective Income Tax Rate Reconciliation Transaction Expense Amount EffectiveIncomeTaxRateReconciliationTransactionExpenseAmount	100000	USD
CY2020	hippo	Effective Income Tax Rate Reconciliation Transaction Expense Amount EffectiveIncomeTaxRateReconciliationTransactionExpenseAmount	100000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-7200000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1100000	USD
CY2021	hippo	Effective Income Tax Rate Reconciliation Nondeductible Expense Interest Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestAmount	5500000	USD
CY2020	hippo	Effective Income Tax Rate Reconciliation Nondeductible Expense Interest Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterestAmount	0	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	53400000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	19900000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-1100000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1200000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	700000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1800000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	200000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	200000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	500000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	700000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	200000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1900000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-100000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2000000.0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	700000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1800000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	87400000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	35400000	USD
CY2021Q4	hippo	Deferred Tax Assets Provision For Commission DeferredTaxAssetsProvisionForCommission	0	USD
CY2020Q4	hippo	Deferred Tax Assets Provision For Commission DeferredTaxAssetsProvisionForCommission	5400000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	3500000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	3100000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2400000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	200000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	2200000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	300000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve	1200000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve	1000000.0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves	600000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves	100000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Trading Securities DeferredTaxAssetsUnrealizedLossesOnTradingSecurities	200000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Trading Securities DeferredTaxAssetsUnrealizedLossesOnTradingSecurities	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	200000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	100000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	3500000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	900000	USD
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	0	USD
CY2020Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	600000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	101200000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	47100000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	93200000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	39600000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	8000000.0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7500000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	300000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	100000	USD
CY2021Q4	hippo	Deferred Tax Liabilities Provision For Commission DeferredTaxLiabilitiesProvisionForCommission	200000	USD
CY2020Q4	hippo	Deferred Tax Liabilities Provision For Commission DeferredTaxLiabilitiesProvisionForCommission	0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Software DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware	6100000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Software DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware	3300000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	200000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	500000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	400000	USD
CY2021Q4	hippo	Deferred Tax Liabilities Stepped Up Adjustment DeferredTaxLiabilitiesSteppedUpAdjustment	0	USD
CY2020Q4	hippo	Deferred Tax Liabilities Stepped Up Adjustment DeferredTaxLiabilitiesSteppedUpAdjustment	2900000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	900000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	300000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	300000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	8000000.0	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	7500000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1100000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	USD
CY2021Q4	hippo	Operating Loss Carryforwards Subject To Expiration OperatingLossCarryforwardsSubjectToExpiration	198700000	USD
CY2021Q4	hippo	Operating Loss Carryforwards Not Subject To Expiration OperatingLossCarryforwardsNotSubjectToExpiration	310500000	USD
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	509200000	USD
CY2020	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	USD
CY2021	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-371400000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-371400000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-141500000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-141500000	USD
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	272168933	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	272168933	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86897893	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86897893	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.36
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.36
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.63
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.63
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	90487042	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	408295877	shares
CY2021	us-gaap	Statutory Accounting Practices Statutory Net Income Amount StatutoryAccountingPracticesStatutoryNetIncomeAmount	-55200000	USD
CY2020	us-gaap	Statutory Accounting Practices Statutory Net Income Amount StatutoryAccountingPracticesStatutoryNetIncomeAmount	-10100000	USD
CY2021Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	139500000	USD
CY2020Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	92200000	USD

Files In Submission

Name	View Source	Status
0001628280-22-006061-index-headers.html	Edgar Link	pending
0001628280-22-006061-index.html	Edgar Link	pending
0001628280-22-006061.txt	Edgar Link	pending
0001628280-22-006061-xbrl.zip	Edgar Link	pending
exhibit21-orgchart.htm	Edgar Link	pending
exhibit231-10xkconsent.htm	Edgar Link	pending
exhibit311-ceo30210k.htm	Edgar Link	pending
exhibit312-cfo30210k.htm	Edgar Link	pending
exhibit321-ceo90610k.htm	Edgar Link	pending
exhibit322-cfo90610k.htm	Edgar Link	pending
exhibit43-descriptionofhip.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hippo-20211231.htm	Edgar Link	pending
hippo-20211231.xsd	Edgar Link	pending
hippo-20211231_cal.xml	Edgar Link	unprocessable
hippo-20211231_def.xml	Edgar Link	unprocessable
hippo-20211231_g1.jpg	Edgar Link	pending
hippo-20211231_g2.jpg	Edgar Link	pending
hippo-20211231_g3.jpg	Edgar Link	pending
hippo-20211231_g4.jpg	Edgar Link	pending
hippo-20211231_g5.jpg	Edgar Link	pending
hippo-20211231_htm.xml	Edgar Link	completed
hippo-20211231_lab.xml	Edgar Link	unprocessable
hippo-20211231_pre.xml	Edgar Link	unprocessable
image_0.jpg	Edgar Link	pending
image_1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HIPO
Hippo Holdings Inc. Stock $hipo

2021 Q4 Form 10-K Financial Statement

#000162828022006061 Filed on March 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HIPO Hippo Holdings Inc. Stock $hipo

2021 Q4 Form 10-K Financial Statement

#000162828022006061 Filed on March 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HIPO
Hippo Holdings Inc. Stock $hipo